Disclosures: Antonio Moreno: Nothing to Disclose, Thomas Issa: Nothing to Disclose, Douglas Farmer: Nothing to Disclose, Edward Wolfgang Lee: Nothing to Disclose 2224 STATIN USE IN CIRRHOSIS CAN DECREASE RISK OF PORTAL HYPERTENSION AND MORTALITY Muhammad Ali Butt 1 Taimur Muzammil 1 Rahul Karna 2 Himsikhar Khataniar 1 Nabeeha Mohy-ud-din 3 , 1 Allegheny General Hospital, Pittsburgh, PA, 2 University of Minnesota Medical Center, 3 Division of Gastroenterology, Hepatology and Nutrition, Allegheny Health Network, Pittsburgh, PA Background: MASLD related cirrhosis is one of the leading etiologies of liver disease, and these patients frequently have other comorbidities like atherosclerotic cardiovascular disease (ASCVD), hyperlipidemia (HLD), cerebrovascular disease (CVD), and diabetes mellitus (DM)
[Abstract]2023 Apr 20;24(8):7608
Non-protein-coding regions There are nearly 25% of mtDNA mutations occurring in non-protein-coding regions including tRNAs and the highly conserved ribosomal RNA [125]
The community envisions this dynamic not only being maintained but enhanced in its desire to keep its authentic elements and natural amenities in a mutually beneficial and harmonious relationship
We can keep track of the whole production history of every kilogram we ship thanks to complete batch tracking
